Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Functional neuroanatomy of the basal ganglia in Parkinson's disease.

Literature DB >> 12442660

Functional neuroanatomy of the basal ganglia in Parkinson's disease.

Thomas Wichmann¹, Mahlon R DeLong.

Abstract

Entities: Disease

Mesh：

Substances：
Dopamine

Year: 2003 PMID： 12442660

Source DB: PubMed Journal: Adv Neurol ISSN： 0091-3952

Keyword Cloud
Cited

× No keyword cloud information.

45 in total

1. Homeostatic regulation of dopaminergic neurons without dopamine.

Authors: D James Surmeier
Journal: Proc Natl Acad Sci U S A Date: 2004-08-30 Impact factor: 11.205

Review 2. Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors: Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal: Neuropsychopharmacology Date: 2011-09-28 Impact factor: 7.853

3. Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors: Andrew H Miller
Journal: Brain Behav Immun Date: 2008-09-03 Impact factor: 7.217

4. Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.

Authors: Jennifer C Felger; Jiyoung Mun; Heather L Kimmel; Jonathon A Nye; Daniel F Drake; Carla R Hernandez; Amanda A Freeman; David B Rye; Mark M Goodman; Leonard L Howell; Andrew H Miller
Journal: Neuropsychopharmacology Date: 2013-05-09 Impact factor: 7.853

Review 5. The striatum and pain modulation.

Authors: Ana C Barceló; Bárbara Filippini; Jorge H Pazo
Journal: Cell Mol Neurobiol Date: 2011-07-26 Impact factor: 5.046

Functional neuroanatomy of the basal ganglia in Parkinson's disease.

1. Homeostatic regulation of dopaminergic neurons without dopamine.

Review 2. Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

3. Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

4. Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.

Review 5. The striatum and pain modulation.

6. Spatially Compact Neural Clusters in the Dorsal Striatum Encode Locomotion Relevant Information.

7. Abnormal regional brain function in Parkinson's disease: truth or fiction?

Review 8. Metabotropic glutamate receptors: physiology, pharmacology, and disease.

9. Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis.

10. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans.